212 related articles for article (PubMed ID: 10853138)
1. New frontiers in brachytherapy.
Nag S
Surg Oncol Clin N Am; 2000 Jul; 9(3):489-502, viii-ix. PubMed ID: 10853138
[TBL] [Abstract][Full Text] [Related]
2. Innovations and advances in brachytherapy.
Stitt JA; Thomadsen BR
Semin Oncol; 1997 Dec; 24(6):696-706. PubMed ID: 9422265
[TBL] [Abstract][Full Text] [Related]
3. Image-guided brachytherapy for prostate cancer.
Rubens DJ; Yu Y; Barnes AS; Strang JG; Brasacchio R
Radiol Clin North Am; 2006 Sep; 44(5):735-48, viii-ix. PubMed ID: 17030224
[TBL] [Abstract][Full Text] [Related]
4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
5. Image-based brachytherapy: a forum for collaboration between radiation oncologists and diagnostic radiologists.
Erickson B
J Am Coll Radiol; 2005 Sep; 2(9):753-8. PubMed ID: 17411923
[TBL] [Abstract][Full Text] [Related]
6. Technological advances in radiotherapy for the treatment of localised prostate cancer.
Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
[TBL] [Abstract][Full Text] [Related]
7. The role of high-dose rate brachytherapy in locally advanced prostate cancer.
Vicini FA; Vargas C; Edmundson G; Kestin L; Martinez A
Semin Radiat Oncol; 2003 Apr; 13(2):98-108. PubMed ID: 12728439
[TBL] [Abstract][Full Text] [Related]
8. [Brachytherapy for prostate cancer].
Yorozu A; Toya K; Ohashi T; Ohsuga K; Ito R; Kasamatsu T; Saito S; Momma T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):424-7. PubMed ID: 16612148
[TBL] [Abstract][Full Text] [Related]
9. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
Cosset JM; Pinillos-Ashton L; Mettler F;
Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
[TBL] [Abstract][Full Text] [Related]
10. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
11. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
12. [Radiation protection issues in brachytherapic treatment of prostatic cancer].
Bellia M; Bellia S; Ciantia F; Luca N; Serafino L; Occhipinti A; Bona R; Mannino G
G Ital Med Lav Ergon; 2007; 29(3 Suppl):781-3. PubMed ID: 18409959
[TBL] [Abstract][Full Text] [Related]
13. High dose rate brachytherapy for prostate cancer.
Hoskin P
Cancer Radiother; 2008 Nov; 12(6-7):512-4. PubMed ID: 18755623
[TBL] [Abstract][Full Text] [Related]
14. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.
Pouliot J; Kim Y; Lessard E; Hsu IC; Vigneron DB; Kurhanewicz J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1196-207. PubMed ID: 15234056
[TBL] [Abstract][Full Text] [Related]
15. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
[TBL] [Abstract][Full Text] [Related]
16. [Advances in brachytherapy--focusing on the permanent implant for early prostate carcinoma].
Hirokawa Y
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2056-61. PubMed ID: 14712765
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer.
Kälkner KM; Bengtsson E; Eriksson S; Holmberg C; Nilsson S; Levitt S; Lundell M
Brachytherapy; 2007; 6(1):49-52. PubMed ID: 17284386
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
19. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer].
Soumarová R; Homola L; Stursa M; Perková H
Cas Lek Cesk; 2006; 145(1):43-9. PubMed ID: 16468241
[TBL] [Abstract][Full Text] [Related]
20. The "Golden Age" of prostate brachytherapy: a cautionary tale.
Aronowitz JN
Brachytherapy; 2008; 7(1):55-9. PubMed ID: 18299114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]